Based on the provided content from CISA, here's an analysis of CVE-2020-16247:

*   **Vulnerability:** Configuration
*   **Root Cause:** The product exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
*   **Affected Product:** Philips Clinical Collaboration Platform Versions 12.2.1 and prior
*   **Impact:** An attacker could modify data or cause a denial of service (DoS).
*   **Attack Vector:** Local access is required.
*   **Attacker Capabilities:** No specific capabilities are mentioned beyond local access.
*   **CVSS v3 Score:** 6.8 (AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:H)
*   **Mitigation:** Update to Philips Clinical Collaboration Platform Version 12.2.5, which remediates this vulnerability.